David Platt - 24 Oct 2024 Form 4/A - Amendment Insider Report for BIOXYTRAN, INC (BIXT)

Role: CEO, Director, 10%+ Owner
Signature: David Platt
Issuer symbol: BIXT
Transactions as of: 24 Oct 2024
Net transactions value: +$2,216,887
Form type: 4/A - Amendment
Filing time: 18 Nov 2025, 15:54:45 UTC
Date Of Original Report: 24 Oct 2024
Previous filing: 20 Aug 2024
Next filing: 28 Oct 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
PLATT DAVID	CEO, Director, 10%+ Owner	12 APPLETON CIRCLE, NEWTON	David Platt	18 Nov 2025	0001166440

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIXT	preferred	Other	$4,014,342	-14,085,410	-100%	$0.2850	0	24 Oct 2024	through NDPD Pharma	F1, F2
transaction	BIXT	preferred	Other	$6,231,229	+11,433,448	+133%	$0.5450	20,038,903	24 Oct 2024	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were returned to treasury and cancelled
F2	The total holdings of BIXT by NDPA Pharma, an affiliate whose beneficial ownership includes David Platt, Ola Soderquist and Mike Sheikh were consolidated under indirect ownership in David Platt's filing
F3	The shares were issued as payment for the sale of NDPD to Bioxytran